Clinical Trials Logo

Clinical Trial Summary

This is a Phase 2b, multi-center, double-blind, randomized, placebo-controlled, parallel-group study of NKT versus placebo in otherwise healthy adults presenting with acute uncomplicated ILI due to influenza or other respiratory viruses in a community setting.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04043923
Study type Interventional
Source Emergo Therapeutics, Inc.
Contact
Status Completed
Phase Phase 2
Start date October 21, 2019
Completion date April 20, 2020

See also
  Status Clinical Trial Phase
Completed NCT04570904 - Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
Not yet recruiting NCT04525118 - Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform
Enrolling by invitation NCT05084898 - Far-UVC Light Devices in Long-term Care Facilities to Reduce Infections N/A
Recruiting NCT05036941 - A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW) N/A
Recruiting NCT05050825 - Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal N/A
Active, not recruiting NCT03965195 - Recombinant Influenza Vaccination in U.S. Nursing Homes Phase 4
Completed NCT05670444 - Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness Phase 1
Recruiting NCT05704335 - InfluenCEF Study: Study on the Headache Associated With Influenza Infection
Completed NCT04610047 - Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness Phase 2
Completed NCT04245800 - Home Testing of Respiratory Illness
Active, not recruiting NCT05012189 - Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks Phase 4
Not yet recruiting NCT04716543 - Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals
Completed NCT04320862 - COVID-19 Pandemic Response Network